{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T18:56:28Z","timestamp":1767725788354,"version":"build-2238731810"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,12,18]],"date-time":"2017-12-18T00:00:00Z","timestamp":1513555200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["PDFMP3_137194\/1."],"award-info":[{"award-number":["PDFMP3_137194\/1."]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Eng Ethics"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s11948-017-0011-3","type":"journal-article","created":{"date-parts":[[2017,12,18]],"date-time":"2017-12-18T03:17:39Z","timestamp":1513567059000},"page":"33-52","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Synthetic Biology and the Translational Imperative"],"prefix":"10.1007","volume":"25","author":[{"given":"Raheleh","family":"Heidari Feidt","sequence":"first","affiliation":[]},{"given":"Marcello","family":"Ienca","sequence":"additional","affiliation":[]},{"given":"Bernice Simone","family":"Elger","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3544-0554","authenticated-orcid":false,"given":"Marc","family":"Folcher","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2017,12,18]]},"reference":[{"issue":"9","key":"11_CR1","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/nm0902-909","volume":"8","author":"T Atkinson","year":"2002","unstructured":"Atkinson, T. (2002). Lifestyle drug market booming. Nature Medicine, 8(9), 909.","journal-title":"Nature Medicine"},{"key":"11_CR2","unstructured":"Balas, E. A., Boren, S. A. (2000). Managing clinical knowledge for health care improvement. In J. Bemmel, A. T. McCray (Eds.), Yearbook of medical informatics 2000: Patient-centered systems (pp. 65\u201370). Stuttgart, Germany: Schattauer Verlagsgesellschaft mbH."},{"issue":"1","key":"11_CR3","first-page":"72","volume":"47","author":"F Belardelli","year":"2011","unstructured":"Belardelli, F., Rizza, P., Moretti, F., Carella, C., Galli, M. C., & Migliaccio, G. (2011). Translational research on advanced therapies. Annali dell\u2019Istituto Superiore Di Sanita, 47(1), 72\u201378.","journal-title":"Annali dell\u2019Istituto Superiore Di Sanita"},{"issue":"6","key":"11_CR4","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/j.1469-8986.2006.00456.x","volume":"43","author":"N Birbaumer","year":"2006","unstructured":"Birbaumer, N. (2006). Breaking the silence: Brain\u2013computer interfaces (BCI) for communication and motor control. Psychophysiology, 43(6), 517\u2013532.","journal-title":"Psychophysiology"},{"issue":"3","key":"11_CR5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1109\/MTS.2015.2461152","volume":"34","author":"T Bonaci","year":"2015","unstructured":"Bonaci, T., Herron, J., Matlack, C., & Chizeck, H. J. (2015). Securing the exocortex: A twenty-first century cybernetics challenge. IEEE Technology and Society Magazine, 34(3), 44\u201351.","journal-title":"IEEE Technology and Society Magazine"},{"issue":"4","key":"11_CR6","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/nrm3767","volume":"15","author":"GM Church","year":"2014","unstructured":"Church, G. M., Elowitz, M. B., Smolke, C. D., Voigt, C. A., & Weiss, R. (2014). Realizing the potential of synthetic biology. Nature Reviews Molecular Cell Biology, 15(4), 289\u2013294.","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"6934","key":"11_CR7","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/nature01626","volume":"422","author":"FS Collins","year":"2003","unstructured":"Collins, F. S., Green, E. D., Guttmacher, A. E., & Guyer, M. S. (2003). A vision for the future of genomics research. Nature, 422(6934), 835\u2013847.","journal-title":"Nature"},{"issue":"5894","key":"11_CR8","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1126\/science.1160622","volume":"321","author":"DG Contopoulos-Ioannidis","year":"2008","unstructured":"Contopoulos-Ioannidis, D. G., Alexiou, G. A., Gouvias, T. C., & Ioannidis, J. (2008). Life cycle of translational research for medical interventions. Science, 321(5894), 1298\u20131299.","journal-title":"Science"},{"issue":"4","key":"11_CR9","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1136\/jme.2009.029785","volume":"36","author":"A Cribb","year":"2010","unstructured":"Cribb, A. (2010). Translational ethics? The theory-practice gap in medical ethics. Journal of Medical Ethics, 36(4), 207\u2013210.","journal-title":"Journal of Medical Ethics"},{"key":"11_CR10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jhealeco.2016.01.012","volume":"47","author":"JA DiMasi","year":"2016","unstructured":"DiMasi, J. A., Grabowski, H. G., & Hansen, R. W. (2016). Innovation in the pharmaceutical industry: New estimates of R&D costs. Journal of Health Economics, 47, 20\u201333.","journal-title":"Journal of Health Economics"},{"issue":"19","key":"11_CR11","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1001\/jama.299.19.2319","volume":"299","author":"D Dougherty","year":"2008","unstructured":"Dougherty, D., & Conway, P. (2008). The \u201c3T\u2019s\u201d road map to transform US health care: The \u201chow\u201d of high-quality care. JAMA, 299(19), 2319\u20132321.","journal-title":"JAMA"},{"key":"11_CR12","unstructured":"Drugs for Neglected Diseases initiative. (2016). 7 New treatments delivered, recommended, and implemented. Retrieved 17\/01\/2017, 2017, from http:\/\/www.dndi.org\/treatments\/ ."},{"key":"11_CR13","unstructured":"El-Mosleh, J. (01 Feb 2016). Immunicum AB: Immunicum\u2019s adenovirus technology gets green light for clinical study. Retrieved 12\/03\/2016, from http:\/\/www.finanznachrichten.de\/nachrichten-2016-02\/36308178-immunicum-ab-immunicum-s-adenovirus-technology-gets-green-light-for-clinical-study-252.htm ."},{"key":"11_CR14","doi-asserted-by":"publisher","unstructured":"Engel-Glatter, S., & Ienca, M. (2017). Life scientists\u2019 views and perspectives on the regulation of dual-use research of concern. Science and Public Policy. https:\/\/doi.org\/10.1093\/scipol\/scx050 .","DOI":"10.1093\/scipol\/scx050"},{"key":"11_CR15","unstructured":"European Commission. (2014). Opinion on synthetic biology I definition. Retrieved 09\/08\/2016, from http:\/\/ec.europa.eu\/health\/scientific_committees\/emerging\/docs\/scenihr_o_044.pdf ."},{"key":"11_CR16","unstructured":"European Commission Press Centre. (2013). EATRIS: Bridging the gap between medical research and clinical applications. Retrieved 03.05.2017, 2017."},{"issue":"2","key":"11_CR17","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1128\/IAI.01318-09","volume":"78","author":"FC Fang","year":"2010","unstructured":"Fang, F. C. (2010). Lost in translation\u2014Basic science in the era of translational research. Infection and Immunity, 78(2), 563\u2013566.","journal-title":"Infection and Immunity"},{"key":"11_CR18","doi-asserted-by":"publisher","first-page":"5392","DOI":"10.1038\/ncomms6392","volume":"5","author":"M Folcher","year":"2014","unstructured":"Folcher, M., Oesterle, S., Zwicky, K., Thekkottil, T., Heymoz, J., Hohmann, M., et al. (2014). Mind-controlled transgene expression by a wireless-powered optogenetic designer cell implant. Nature Communications, 5, 5392.","journal-title":"Nature Communications"},{"issue":"5895","key":"11_CR19","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1126\/science.321.5895.1443a","volume":"321","author":"A Gaggioli","year":"2008","unstructured":"Gaggioli, A., & Riva, G. (2008). Working the crowd. Science, 321(5895), 1443.","journal-title":"Science"},{"key":"11_CR20","first-page":"1","volume":"23","author":"R Heidari","year":"2016","unstructured":"Heidari, R., Shaw, D. M., & Elger, B. S. (2016). CRISPR and the rebirth of synthetic biology. Science and Engineering Ethics, 23, 1\u201313.","journal-title":"Science and Engineering Ethics"},{"key":"11_CR21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.copbio.2015.01.010","volume":"35","author":"BC Heng","year":"2015","unstructured":"Heng, B. C., Aubel, D., & Fussenegger, M. (2015). Prosthetic gene networks as an alternative to standard pharmacotherapies for metabolic disorders. Current Opinion in Biotechnology, 35, 37\u201345.","journal-title":"Current Opinion in Biotechnology"},{"key":"11_CR22","unstructured":"Herper, M. (2016). Juno therapeutics stops trial of cancer-killing cells after 3 patient deaths. Forbes Retrieved 11\/08\/2016."},{"issue":"7","key":"11_CR23","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/nm0705-705","volume":"11","author":"H H\u00f6rig","year":"2005","unstructured":"H\u00f6rig, H., Marincola, E., & Marincola, F. M. (2005). Obstacles and opportunities in translational research. Nature Medicine, 11(7), 705\u2013708.","journal-title":"Nature Medicine"},{"issue":"5","key":"11_CR24","doi-asserted-by":"publisher","first-page":"e718","DOI":"10.1371\/journal.pntd.0000718","volume":"4","author":"PJ Hotez","year":"2010","unstructured":"Hotez, P. J., & Pecoul, B. (2010). \u201cManifesto\u201d for advancing the control and elimination of neglected tropical diseases. PLOS Neglected Tropical Diseases, 4(5), e718.","journal-title":"PLOS Neglected Tropical Diseases"},{"key":"11_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10676-016-9398-9","volume":"18","author":"M Ienca","year":"2016","unstructured":"Ienca, M., & Haselager, P. (2016). Hacking the brain: Brain\u2013computer interfacing technology and the ethics of neurosecurity. Ethics and Information Technology, 18, 1\u201313.","journal-title":"Ethics and Information Technology"},{"key":"11_CR26","unstructured":"Iorns, E. (12 June 2013). Research 2.0.1: The future of research funding. Soapbox science Retrieved 12\/03\/2016, from http:\/\/blogs.nature.com\/soapboxscience\/2013\/06\/12\/research-2-0-1-the-future-of-research-funding ."},{"issue":"4","key":"11_CR27","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nbt.1617","volume":"28","author":"C Kemmer","year":"2010","unstructured":"Kemmer, C., Gitzinger, M., Daoud-El Baba, M., Djonov, V., Stelling, J., & Fussenegger, M. (2010). Self-sufficient control of urate homeostasis in mice by a synthetic circuit. Nature Biotechnology, 28(4), 355\u2013360.","journal-title":"Nature Biotechnology"},{"issue":"10","key":"11_CR28","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1097\/GIM.0b013e31815699d0","volume":"9","author":"MJ Khoury","year":"2007","unstructured":"Khoury, M. J., Gwinn, M., Yoon, P. W., Dowling, N., Moore, C. A., & Bradley, L. (2007). The continuum of translation research in genomic medicine: How can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genetics in Medicine, 9(10), 665\u2013674.","journal-title":"Genetics in Medicine"},{"issue":"7482","key":"11_CR29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1136\/bmj.330.7482.79","volume":"330","author":"J Kimmelman","year":"2005","unstructured":"Kimmelman, J. (2005). Recent developments in gene transfer: Risk and ethics. BMJ, 330(7482), 79\u201382.","journal-title":"BMJ"},{"issue":"3","key":"11_CR30","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/dewb_154.x","volume":"7","author":"J Kimmelman","year":"2007","unstructured":"Kimmelman, J. (2007). Clinical trials and SCID row: The ethics of phase 1 trials in the developing world. Developing World Bioethics, 7(3), 128\u2013135.","journal-title":"Developing World Bioethics"},{"issue":"3","key":"11_CR31","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nrg2317","volume":"9","author":"J Kimmelman","year":"2008","unstructured":"Kimmelman, J. (2008). The ethics of human gene transfer. Nature Reviews Genetics, 9(3), 239\u2013244.","journal-title":"Nature Reviews Genetics"},{"issue":"3","key":"11_CR32","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1748-720X.2002.tb00407.x","volume":"30","author":"NM King","year":"2002","unstructured":"King, N. M. (2002). RAC oversight of gene transfer research: A model worth extending? The Journal of Law, Medicine and Ethics, 30(3), 381\u2013389.","journal-title":"The Journal of Law, Medicine and Ethics"},{"issue":"106","key":"11_CR33","doi-asserted-by":"publisher","first-page":"20141000","DOI":"10.1098\/rsif.2014.1000","volume":"12","author":"Z Kis","year":"2015","unstructured":"Kis, Z., Pereira, H. S., Homma, T., Pedrigi, R. M., & Krams, R. (2015). Mammalian synthetic biology: Emerging medical applications. Journal of the Royal Society, Interface, 12(106), 20141000.","journal-title":"Journal of the Royal Society, Interface"},{"issue":"22","key":"11_CR34","doi-asserted-by":"publisher","first-page":"8414","DOI":"10.1073\/pnas.0402940101","volume":"101","author":"H Kobayashi","year":"2004","unstructured":"Kobayashi, H., Kaern, M., Araki, M., Chung, K., Gardner, T. S., Cantor, C. R., et al. (2004). Programmable cells: Interfacing natural and engineered gene networks. Proceedings of the National Academy of Sciences of the United States of America, 101(22), 8414\u20138419.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"11_CR35","first-page":"11","volume":"14","author":"H K\u00f6nig","year":"2013","unstructured":"K\u00f6nig, H., Frank, D., Heil, R., & Coenen, C. (2013). Synthetic genomics and synthetic biology applications between hopes and concerns. Current Genomics, 14(1), 11\u201324.","journal-title":"Current Genomics"},{"key":"11_CR36","doi-asserted-by":"crossref","DOI":"10.2307\/j.ctv1q3z2k3","volume-title":"Whose view of life? Embryos, cloning, and stem cells","author":"J Maienschein","year":"2009","unstructured":"Maienschein, J., & Maienschein, J. (2009). Whose view of life? Embryos, cloning, and stem cells. Cambridge: Harvard University Press."},{"issue":"3","key":"11_CR37","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/15265160802109314","volume":"8","author":"J Maienschein","year":"2008","unstructured":"Maienschein, J., Sunderland, M., Ankeny, R. A., & Robert, J. S. (2008). The ethos and ethics of translational research. The American Journal of Bioethics, 8(3), 43\u201351.","journal-title":"The American Journal of Bioethics"},{"issue":"3","key":"11_CR38","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1080\/15265160802109462","volume":"8","author":"K Morin","year":"2008","unstructured":"Morin, K. (2008). Translational research: A new social contract that still leaves out public health? The American Journal of Bioethics, 8(3), 62\u201364.","journal-title":"The American Journal of Bioethics"},{"issue":"12","key":"11_CR39","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1258\/jrsm.2011.110180","volume":"104","author":"ZS Morris","year":"2011","unstructured":"Morris, Z. S., Wooding, S., & Grant, J. (2011). The answer is 17\u00a0years, what is the question: Understanding time lags in translational research. Journal of the Royal Society of Medicine, 104(12), 510\u2013520.","journal-title":"Journal of the Royal Society of Medicine"},{"key":"11_CR40","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1096\/fj.01-0540lsf","volume":"15","author":"Jordan S Pober","year":"2001","unstructured":"Pober, Jordan S., Neuhauser, Crystal S., & Pober, J. M. (2001). Obstacles facing translational research in academic medical centers. The FASEB Journal, 15, 2303\u20132313.","journal-title":"The FASEB Journal"},{"issue":"6","key":"11_CR41","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/nrm2698","volume":"10","author":"PE Purnick","year":"2009","unstructured":"Purnick, P. E., & Weiss, R. (2009). The second wave of synthetic biology: From modules to systems. Nature Reviews Molecular Cell Biology, 10(6), 410\u2013422.","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"4","key":"11_CR42","doi-asserted-by":"publisher","first-page":"e1001530","DOI":"10.1371\/journal.pbio.1001530","volume":"11","author":"KH Redford","year":"2013","unstructured":"Redford, K. H., Adams, W., & Mace, G. M. (2013). Synthetic biology and conservation of nature: Wicked problems and wicked solutions. PLoS Biology, 11(4), e1001530.","journal-title":"PLoS Biology"},{"issue":"3","key":"11_CR43","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/ACM.0b013e3181ccc877","volume":"85","author":"SE Reis","year":"2010","unstructured":"Reis, S. E., Berglund, L., Bernard, G. R., Califf, R. M., FitzGerald, G. A., & Johnson, P. C. (2010). Reengineering the national clinical and translational research enterprise: The strategic plan of the national clinical and translational science awards consortium. Academic Medicine: Journal of the Association of American Medical Colleges, 85(3), 463.","journal-title":"Academic Medicine: Journal of the Association of American Medical Colleges"},{"issue":"1","key":"11_CR44","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/jmp\/19.1.23","volume":"19","author":"D Resnik","year":"1994","unstructured":"Resnik, D. (1994). Debunking the slippery slope argument against human germ-line gene therapy. Journal of Medicine and Philosophy, 19(1), 23\u201340.","journal-title":"Journal of Medicine and Philosophy"},{"key":"11_CR45","volume-title":"The right and the good","author":"WD Ross","year":"1930","unstructured":"Ross, W. D. (1930). The right and the good. Oxford: The Clarendon Press."},{"issue":"45","key":"11_CR46","doi-asserted-by":"publisher","first-page":"18150","DOI":"10.1073\/pnas.1312414110","volume":"110","author":"K R\u00f6ssger","year":"2013","unstructured":"R\u00f6ssger, K., Charpin El Hamri, G., & Fussenegger, M. (2013). Reward-based hypertension control by a synthetic brain\u2013dopamine interface. Proceedings of the National Academy of Sciences of the United States of America, 110(45), 18150\u201318155.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"11_CR47","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/978-0-387-33225-3_12","volume-title":"Ethical and legal issues in the conduct of cancer clinical trials. Cancer clinical trials: Proactive strategies","author":"GJ Sands","year":"2007","unstructured":"Sands, G. J., & Means, P. A. (2007). Ethical and legal issues in the conduct of cancer clinical trials. Cancer clinical trials: Proactive strategies (pp. 219\u2013229). Berlin: Springer."},{"issue":"3","key":"11_CR48","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1136\/jme.27.3.148","volume":"27","author":"J Savulescu","year":"2001","unstructured":"Savulescu, J. (2001). Harm, ethics committees and the gene therapy death. Journal of Medical Ethics, 27(3), 148\u2013150.","journal-title":"Journal of Medical Ethics"},{"key":"11_CR49","unstructured":"Scarff, L. (June 15 2013). iCancer hits its goal raising \u00a32 million. Retrieved 16\/03\/2016, from http:\/\/icancer.org.uk\/icancer-hits-its-goal-raising-2million\/ ."},{"key":"11_CR50","unstructured":"Schmid, F. (2010). \u201cMolecular prosthesis against gout.\u201d Retrieved 30\/03\/2016, from http:\/\/www.ethlife.ethz.ch\/archive_articles\/100329_fussenegger_paper_fs\/index_EN ."},{"issue":"387","key":"11_CR51","doi-asserted-by":"publisher","first-page":"eaal2298","DOI":"10.1126\/scitranslmed.aal2298","volume":"9","author":"J Shao","year":"2017","unstructured":"Shao, J., Xue Shuai, Yu., Yuanhuan, Guiling, Yu., Xueping, Yang, Bai, Yu., Sucheng, Zhu, et al. (2017). Smartphone-controlled optogenetically engineered cells enable semiautomatic glucose homeostasis in diabetic mice. Science Translational Medicine, 9(387), eaal2298.","journal-title":"Science Translational Medicine"},{"issue":"3","key":"11_CR52","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.mayocp.2011.12.008","volume":"87","author":"JJ Shih","year":"2012","unstructured":"Shih, J. J., Krusienski, D. J., & Wolpaw, J. R. (2012). Brain\u2013computer interfaces in medicine. Mayo Clinic Proceedings, 87(3), 268\u2013279.","journal-title":"Mayo Clinic Proceedings"},{"issue":"30","key":"11_CR53","doi-asserted-by":"publisher","first-page":"30cm16","DOI":"10.1126\/scitranslmed.3000169","volume":"2","author":"BM Silber","year":"2010","unstructured":"Silber, B. M. (2010). Driving drug discovery: The fundamental role of academic labs. Science Translational Medicine, 2(30), 30cm16.","journal-title":"Science Translational Medicine"},{"issue":"8","key":"11_CR54","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/15265161.2010.494214","volume":"10","author":"N Sofaer","year":"2010","unstructured":"Sofaer, N., & Eyal, N. (2010). The diverse ethics of translational research. The American Journal of Bioethics, 10(8), 19\u201330.","journal-title":"The American Journal of Bioethics"},{"issue":"1","key":"11_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1667\/RR3030","volume":"160","author":"J Sugarman","year":"2003","unstructured":"Sugarman, J., & McKenna, W. G. (2003). Ethical hurdles for translational research. Radiation Research, 160(1), 1\u20134.","journal-title":"Radiation Research"},{"issue":"10","key":"11_CR56","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1001\/jama.289.10.1278","volume":"289","author":"NS Sung","year":"2003","unstructured":"Sung, N. S. (2003). Central challenges facing the national clinical research enterprise. JAMA, 289(10), 1278.","journal-title":"JAMA"},{"key":"11_CR57","unstructured":"Thomas, J. (2013). Why synthetic artemisinin is still a bad idea\u2014A response to rob carlson. from http:\/\/www.etcgroup.org\/content\/why-synthetic-artemisinin-still-bad-idea-response-rob-carlson ."},{"issue":"3","key":"11_CR58","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1752-8062.2011.00291.x","volume":"4","author":"W Trochim","year":"2011","unstructured":"Trochim, W., Kane, C., Graham, M. J., & Pincus, H. A. (2011). Evaluating translational research: A process marker model. Clinical and Translational Science, 4(3), 153\u2013162.","journal-title":"Clinical and Translational Science"},{"key":"11_CR59","unstructured":"Tufts Center for the Study of Drug Development. (18 Nov 2014). Cost to develop and win marketing approval for a new drug is $2.6 billion. Retrieved 11\/03\/2016, from http:\/\/csdd.tufts.edu\/news\/complete_story\/pr_tufts_csdd_2014_cost_study ."},{"key":"11_CR60","unstructured":"US Department of Health and Human Services Food and Drug Administration (2004). Innovation or stagnation: Challenge and opportunity on the critical path to new medical products."},{"key":"11_CR61","unstructured":"US Department of Health and Human Services Food and Drug Administration (2006). Guidance for industry, investigators, and reviewers exploratory IND studies."},{"key":"11_CR62","unstructured":"US Food and Drug Administration. (2004). FDA\u2019s critical path initiative. Retrieved 03.05.2017, 2017."},{"issue":"4","key":"11_CR63","first-page":"26","volume":"45","author":"JBF Erp Van","year":"2012","unstructured":"Van Erp, J. B. F., Lotte, F., & Tangermann, M. (2012). Brain\u2013computer interfaces: Beyond medical applications. IEEE, 45(4), 26\u201334.","journal-title":"IEEE"},{"issue":"4","key":"11_CR64","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1001\/jama.297.4.403","volume":"297","author":"JM Westfall","year":"2007","unstructured":"Westfall, J. M., Mold, J., & Fagnan, L. (2007). Practice-based research\u2014\u201cBlue highways\u201d on the NIH roadmap. JAMA, 297(4), 403\u2013406.","journal-title":"JAMA"},{"key":"11_CR65","unstructured":"World Health Organization. (2004). The world medicines situation. Retrieved 17\/03\/2016, from http:\/\/apps.who.int\/medicinedocs\/en\/d\/Js6160e\/ ."},{"issue":"6317","key":"11_CR66","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1126\/science.aaf4006","volume":"354","author":"M Xie","year":"2016","unstructured":"Xie, M., Ye, H., Wang, H., Hamri, G. C.-E., Lormeau, C., Saxena, P., et al. (2016). \u03b2-cell\u2013mimetic designer cells provide closed-loop glycemic control. Science, 354(6317), 1296\u20131301.","journal-title":"Science"},{"issue":"3","key":"11_CR67","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1126\/science.1091867","volume":"302","author":"E Zerhouni","year":"2003","unstructured":"Zerhouni, E. (2003). The NIH roadmap. Science, 302(3), 63\u201372.","journal-title":"Science"}],"updated-by":[{"DOI":"10.1007\/s11948-018-0019-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,1,24]],"date-time":"2018-01-24T00:00:00Z","timestamp":1516752000000}}],"container-title":["Science and Engineering Ethics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11948-017-0011-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11948-017-0011-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11948-017-0011-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T15:52:05Z","timestamp":1660146725000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11948-017-0011-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,18]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["11"],"URL":"https:\/\/doi.org\/10.1007\/s11948-017-0011-3","relation":{},"ISSN":["1353-3452","1471-5546"],"issn-type":[{"value":"1353-3452","type":"print"},{"value":"1471-5546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,18]]},"assertion":[{"value":"18 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This work was supported by grant No. 137194 of the Swiss National Science Foundation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"All authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}